Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 332

1.

Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy.

Aasbjerg K, Backer V, Lund G, Holm J, Nielsen NC, Holse M, Wagtmann VR, Würtzen PA.

Clin Exp Allergy. 2014 Mar;44(3):417-28.

PMID:
24734285
2.

Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.

Schmid JM, Würtzen PA, Dahl R, Hoffmann HJ.

J Allergy Clin Immunol. 2016 Feb;137(2):562-70. doi: 10.1016/j.jaci.2015.05.023. Epub 2015 Jun 30.

PMID:
26141262
3.

Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.

Chaker AM, Shamji MH, Dumitru FA, Calderon MA, Scadding GW, Makatsori M, Jones I, He QA, Subramanian KK, Arm JP, Durham SR, Schmidt-Weber CB.

J Allergy Clin Immunol. 2016 Feb;137(2):452-461.e9. doi: 10.1016/j.jaci.2015.08.046. Epub 2015 Oct 31.

PMID:
26531865
4.
5.

Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.

Gadermaier E, Staikuniene J, Scheiblhofer S, Thalhamer J, Kundi M, Westritschnig K, Swoboda I, Flicker S, Valenta R.

Allergy. 2011 Sep;66(9):1174-82. doi: 10.1111/j.1398-9995.2011.02592.x. Epub 2011 Apr 11.

PMID:
21480924
6.

Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.

Baron-Bodo V, Horiot S, Lautrette A, Chabre H, Drucbert AS, Danzé PM, Sénéchal H, Peltre G, Galvain S, Zeldin RK, Horak F, Moingeon P.

Clin Exp Allergy. 2013 Dec;43(12):1362-73. doi: 10.1111/cea.12187.

PMID:
24261946
7.

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.

Zieglmayer P, Focke-Tejkl M, Schmutz R, Lemell P, Zieglmayer R, Weber M, Kiss R, Blatt K, Valent P, Stolz F, Huber H, Neubauer A, Knoll A, Horak F, Henning R, Valenta R.

EBioMedicine. 2016 Sep;11:43-57. doi: 10.1016/j.ebiom.2016.08.022. Epub 2016 Aug 20.

8.

Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.

Van Overtvelt L, Baron-Bodo V, Horiot S, Moussu H, Ricarte C, Horak F, Zieglmayer P, Zieglmayer R, Montagut A, Galvain S, de Beaumont O, Le Gall M, Moingeon P.

Allergy. 2011 Dec;66(12):1530-7. doi: 10.1111/j.1398-9995.2011.02696.x. Epub 2011 Aug 29.

PMID:
21883279
9.

Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.

Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.

Clin Ther. 2011 Jul;33(7):828-40. doi: 10.1016/j.clinthera.2011.06.006. Epub 2011 Jul 7.

PMID:
21741092
10.

SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis.

Dahl R, Roberts G, de Blic J, Canonica GW, Kleine-Tebbe J, Nolte H, Lawton S, Nelson HS.

Allergy Asthma Proc. 2016 Mar-Apr;37(2):92-104. doi: 10.2500/aap.2016.37.3937. Epub 2016 Jan 21.

PMID:
26802643
11.

Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.

Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G.

J Allergy Clin Immunol. 2012 Nov;130(5):1097-1107.e2. doi: 10.1016/j.jaci.2012.08.012. Epub 2012 Sep 27.

PMID:
23021885
12.

Japanese cedar pollen-based subcutaneous immunotherapy decreases tomato fruit-specific basophil activation.

Inuo C, Kondo Y, Tanaka K, Nakajima Y, Nomura T, Ando H, Suzuki S, Tsuge I, Yoshikawa T, Urisu A.

Int Arch Allergy Immunol. 2015;167(2):137-45. doi: 10.1159/000437325. Epub 2015 Aug 18.

13.

Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study.

Zidarn M, Košnik M, Šilar M, Bajrović N, Korošec P.

Allergy. 2015 May;70(5):547-55. doi: 10.1111/all.12581. Epub 2015 Feb 24.

PMID:
25627309
14.
15.

Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy.

Shamji MH, Ljørring C, Francis JN, Calderon MA, Larché M, Kimber I, Frew AJ, Ipsen H, Lund K, Würtzen PA, Durham SR.

Allergy. 2012 Feb;67(2):217-26. doi: 10.1111/j.1398-9995.2011.02745.x. Epub 2011 Nov 14.

PMID:
22077562
16.

Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.

Gadermaier E, Flicker S, Aberer W, Egger C, Reider N, Focke M, Vrtala S, Kundi M, Valenta R.

Int Arch Allergy Immunol. 2010;151(1):17-27. doi: 10.1159/000232567. Epub 2009 Aug 6.

PMID:
19672093
17.

Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells.

Scadding GW, Shamji MH, Jacobson MR, Lee DI, Wilson D, Lima MT, Pitkin L, Pilette C, Nouri-Aria K, Durham SR.

Clin Exp Allergy. 2010 Apr;40(4):598-606. doi: 10.1111/j.1365-2222.2010.03462.x. Epub 2010 Feb 22.

PMID:
20184605
18.

Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response.

Shamji MH, Layhadi JA, Scadding GW, Cheung DK, Calderon MA, Turka LA, Phippard D, Durham SR.

J Allergy Clin Immunol. 2015 Apr;135(4):913-21.e9. doi: 10.1016/j.jaci.2014.09.049. Epub 2014 Nov 22.

PMID:
25457150
19.

Pre-seasonal, subcutaneous immunotherapy: a double-blinded, placebo-controlled study in elderly patients with an allergy to grass.

Bozek A, Kolodziejczyk K, Krajewska-Wojtys A, Jarzab J.

Ann Allergy Asthma Immunol. 2016 Feb;116(2):156-61. doi: 10.1016/j.anai.2015.12.013.

PMID:
26815709
20.

Dose dependence of immunological response to sublingual immunotherapy.

Marcucci F, Sensi L, Di Cara G, Incorvaia C, Frati F.

Allergy. 2005 Jul;60(7):952-6.

PMID:
15932387

Supplemental Content

Support Center